BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37300687)

  • 1. MiR-188-5p inhibits cell proliferation and migration in ovarian cancer via competing for CCND2 with ELAVL1.
    Zhang H; Yuan N; Che H; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):69-74. PubMed ID: 37300687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer.
    Chang L; Guo R; Yuan Z; Shi H; Zhang D
    Cell Physiol Biochem; 2018; 49(4):1289-1303. PubMed ID: 30205383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
    Hu W; Li H; Wang S
    BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of miR-192-5p inhibits the ELAVL1/PI3Kδ axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy.
    Fu XL; He FT; Li MH; Fu CY; Chen JZ
    Diabet Med; 2023 Sep; 40(9):e15077. PubMed ID: 36861382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of microRNA-432-5p by DNA methyltransferase 3B leads to development of colorectal cancer through upregulation of CCND2.
    Yun Z; Yue M; Kang Z; Zhang P
    Exp Cell Res; 2022 Jan; 410(1):112936. PubMed ID: 34801563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
    Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
    Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
    J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-324-5p Inhibits Proliferation and Invasion of Colorectal Cancer Cells by Targeting ELAVL1.
    Gu C; Zhang M; Sun W; Dong C
    Oncol Res; 2019 May; 27(5):515-524. PubMed ID: 29386086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA TTTY15 silencing inhibits gastric cancer progression by sponging microRNA-98-5p to down-regulate cyclin D2 expression.
    Wen X; Han W; Liu C
    Bioengineered; 2022 Mar; 13(3):7380-7391. PubMed ID: 35266852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF4.
    Wu Z; Guo J; Zhang Y; Liu J; Ma H; Tang Y
    J Ovarian Res; 2021 Oct; 14(1):138. PubMed ID: 34686190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.